Cover Image
市場調查報告書

Boston Biomedical, Inc. - 產品平台分析

Boston Biomedical, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256110
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Boston Biomedical, Inc. - 產品平台分析 Boston Biomedical, Inc. - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 31 Pages
簡介

Boston Biomedical, Inc.是開發新癌症治療藥的生物科技企業。該公司正在發展藥物研發、結晶學、醫藥品化學、前臨床開發、藥理學、醫藥開發、全球性臨床試驗、藥事法規等癌症治療藥的研究。其結果便是開發了超過10個癌症相關的計劃、5個以上臨床階段計劃。

本報告提供Boston Biomedical, Inc.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Boston Biomedical, Inc.的基本資料

Boston Biomedical, Inc.概要

  • 主要資訊
  • 企業資料

Boston Biomedical, Inc.:R&D概要

  • 主要的治療範圍

Boston Biomedical, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Boston Biomedical, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨階段的產品/聯合治療模式

Boston Biomedical, Inc.:藥物簡介

  • BBI-608
  • BBI-503
  • Cancer Stem Cells for Oncology

Boston Biomedical, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Boston Biomedical, Inc.:最近的開發平台趨勢

Boston Biomedical, Inc.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07138CDB

Summary

Global Markets Direct's, 'Boston Biomedical, Inc. - Product Pipeline Review - 2015', provides an overview of the Boston Biomedical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Boston Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Boston Biomedical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Boston Biomedical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Boston Biomedical, Inc.'s pipeline products

Reasons to buy

  • Evaluate Boston Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Boston Biomedical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Boston Biomedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Boston Biomedical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Boston Biomedical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Boston Biomedical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Boston Biomedical, Inc. Snapshot
    • Boston Biomedical, Inc. Overview
    • Key Information
    • Key Facts
  • Boston Biomedical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Boston Biomedical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Boston Biomedical, Inc. - Pipeline Products Glance
    • Boston Biomedical, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Boston Biomedical, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Boston Biomedical, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Boston Biomedical, Inc. - Drug Profiles
    • napabucasin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBI-503
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • napabucasin + BBI-503
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules targeting Cancer Stem Cells for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Boston Biomedical, Inc. - Pipeline Analysis
    • Boston Biomedical, Inc. - Pipeline Products by Target
    • Boston Biomedical, Inc. - Pipeline Products by Route of Administration
    • Boston Biomedical, Inc. - Pipeline Products by Molecule Type
    • Boston Biomedical, Inc. - Pipeline Products by Mechanism of Action
  • Boston Biomedical, Inc. - Recent Pipeline Updates
  • Boston Biomedical, Inc. - Dormant Projects
  • Boston Biomedical, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Boston Biomedical, Inc., Key Information
  • Boston Biomedical, Inc., Key Facts
  • Boston Biomedical, Inc. - Pipeline by Indication, 2015
  • Boston Biomedical, Inc. - Pipeline by Stage of Development, 2015
  • Boston Biomedical, Inc. - Monotherapy Products in Pipeline, 2015
  • Boston Biomedical, Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Boston Biomedical, Inc. - Phase III, 2015
  • Boston Biomedical, Inc. - Phase II, 2015
  • Boston Biomedical, Inc. - Phase I, 2015
  • Boston Biomedical, Inc. - Preclinical, 2015
  • Boston Biomedical, Inc. - Pipeline by Target, 2015
  • Boston Biomedical, Inc. - Pipeline by Route of Administration, 2015
  • Boston Biomedical, Inc. - Pipeline by Molecule Type, 2015
  • Boston Biomedical, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Boston Biomedical, Inc. - Recent Pipeline Updates, 2015
  • Boston Biomedical, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Boston Biomedical, Inc. - Pipeline by Top 10 Indication, 2015
  • Boston Biomedical, Inc. - Pipeline by Stage of Development, 2015
  • Boston Biomedical, Inc. - Monotherapy Products in Pipeline, 2015
  • Boston Biomedical, Inc. - Pipeline by Top 10 Target, 2015
  • Boston Biomedical, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Boston Biomedical, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Boston Biomedical, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top